Paul Drayson plans raising $78M via new AI drug research firm's IPO
Note: This section contains information in English only.
Tue, 07 Aug 2018 09:39:08 GMT
Source: Dukascopy Bank SA
Paul Drayson, Britain's biotech entrepreneur, is eager to attract $78M through a new AI drug research company's initial public offering, planning to list on the London AIM market the following week.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.